metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-114 APPLICATION OF THE DONOR RISK INDEX IN LIVER TRANSPLANTATION IN THE MAIN T...
Información de la revista
Vol. 28. Núm. S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 28. Núm. S1.
Abstracts of the 2022 Annual Meeting of the ALEH
(marzo 2023)
Acceso a texto completo
P-114 APPLICATION OF THE DONOR RISK INDEX IN LIVER TRANSPLANTATION IN THE MAIN TRANSPLANT CENTER IN PERU
Visitas
290
P.Martin Padilla-Machaca1,2, Omar Mantilla1, José Rivera1, Alfonso Solar1, Bertha Cárdenas1, Carmen Cerrón1, Saul Espinoza1, Wilmer Bacilio1, A Montufar1, Carlos Rondón1
1 Transplant Department. Guillermo Almenara National Hospital. Lima, Perú
2 National Univesity of San Marcos. Lima, Perú
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Descargar PDF
Estadísticas
Tablas (1)
Suplemento especial
Este artículo forma parte de:
Vol. 28. Núm S1

Abstracts of the 2022 Annual Meeting of the ALEH

Más datos
Introduction and Objectives

The evaluation of cadaveric donors through the application of the donor-recipient risk index (DRI) since 2006 in the USA has been useful in the standardization of criteria during organ allocation in liver transplantation. This study aimed to apply the DRI > or < 1.7 and the relationship with morbidity and mortality, hospital stay, post-reperfusion syndrome, diagnosis, and origin, steatosis, BMI, cold ischemia times (WIT), Child-Pugh score and MELD score in our center.

Materials and Methods

Descriptive, cross-sectional, retrospective study. The medical records of all liver transplant patients were reviewed to extract demographic data and clinical characteristics based on the criteria established in the DRI assessment.

Results

78 patients out of 303 met the criteria for evaluation registration, DRI < 1.7: 70.51% (mortality 16.36%), DRI > 1.7: 29.8% (mortality: 30.43). Post reperfusion syndrome: 47.82%. Cause of brain death: Traumatic brain injury: 43.58%, stroke: 41.02%, anoxic brain injury: 11.53%. Male: 60.25% and female: 39.74%. Donor graft weight: IDR <1.7: 1412 gr (700-2440g), WIT: 5.91 h (1.38-11.4 h), Age: 31 y (10-55), BMI: 24.93 (12.11-33.33), brain death time: 24 h and admission time: 4.3 hours, in the group with DRI > 1.7 graft weight: 1407 g (336-1900), WIT: 7.4 h (4-12.24), age: 51.22 y (29-67), BMI: 26.27 (26.23-29.38), brain death time: 24.5 h and admission time: 3 h. DRI group < 1.7: mild steatosis: 80%, moderate: 18% and in the IDR group > 1.7: mild steatosis: 87% and moderate in 13%. (see table 1)

Conclusions

Medical-surgical morbidity and mortality, post-reperfusion syndrome, hospital stay, stroke, BMI, and use of SPLIT grafts were higher in patients with IDR > 1.7. Other variables studied had no statistical relationship. We conclude that the IDR should be included in the evaluation of donors in our reality.

Texto completo

Table 1. results of 78 patients out of 303 met the criteria for evaluation registration

DRI  < 1.7  >1.7 
Mortality  16.36  30.43 
Surgical morbilty  18  32.72  12  52.17 
Medical morbility  28  50.9  15  65.21 
Post Reperfusion Syndrome  15  27.27  11  47.82 
Admission time (h)  17.41 (120—-5)    24.21 (5–90)   

Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos